Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Photocure ASA

Market Cap 158.84Cr 17Cr 14Cr 13Cr 12Cr 23Cr 1.59TCr 24Cr 157.3Cr 61Cr 774.36Cr 63Cr 61Cr 2.68TCr P/E Ratio 2026 *
19.6x
P/E Ratio 2027 * 31.2x
Enterprise Value 126.54Cr 13Cr 12Cr 11Cr 9.93Cr 19Cr 1.27TCr 19Cr 125.31Cr 49Cr 616.9Cr 50Cr 49Cr 2.14TCr EV / Sales 2026 *
1.99x
EV / Sales 2027 * 1.81x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.34%
1 week+2.23%
Current month-4.03%
1 month-5.10%
3 months-11.59%
6 months-8.04%
Current year-16.67%
1 week 56.2
Extreme 56.2
60.9
1 month 56.2
Extreme 56.2
67.8
Current year 55.2
Extreme 55.2
79.8
1 year 49.5
Extreme 49.5
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
146.5
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Executive Officer - 01/07/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap.
02/25/02BuyCompany 8,997 0.0332%
02/25/02BuyCompany 11,355 0.0419%
31/25/31BuyCompany 21,105 0.0778%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%+2.23%+18.06%+19.00% 17Cr
-0.68%-2.75%+38.38%+146.18% 1,01000Cr
-1.43%+2.05%+52.63%+44.70% 58TCr
-2.68%-0.34%+16.48%+63.59% 40TCr
-0.24%0.00%+21.28%+19.14% 33TCr
-1.11%+2.57%+24.89%+33.19% 28TCr
-1.77%-4.33%+22.00%+12.94% 28TCr
-0.09%+4.80%-42.77%-48.38% 20TCr
-0.14%+2.19%+19.54%+54.66% 19TCr
-0.11%-3.20%+11.88%+56.96% 16TCr
Average -0.83%+0.89%+18.24%+40.20% 34.29TCr
Weighted average by Cap. -1.00%+1.04%+27.20%+66.58%

Financials

2026 *2027 *
Net sales 63Cr 6.69Cr 5.77Cr 5.32Cr 4.98Cr 9.33Cr 635.5Cr 9.48Cr 63Cr 24Cr 309.32Cr 25Cr 25Cr 1.07TCr 68Cr 7.12Cr 6.15Cr 5.67Cr 5.3Cr 9.94Cr 676.56Cr 10Cr 67Cr 26Cr 329.31Cr 27Cr 26Cr 1.14TCr
Net income 8.15Cr 85.88L 74.17L 68.35L 63.98L 1.2Cr 82Cr 1.22Cr 8.07Cr 3.15Cr 40Cr 3.22Cr 3.15Cr 137.57Cr 5.1Cr 53.74L 46.42L 42.77L 40.04L 75.03L 51Cr 76.19L 5.05Cr 1.97Cr 25Cr 2.02Cr 1.97Cr 86Cr
Net Debt -32Cr -3.4Cr -2.94Cr -2.71Cr -2.54Cr -4.75Cr -323.51Cr -4.83Cr -32Cr -12Cr -157.46Cr -13Cr -13Cr -545.22Cr -36Cr -3.85Cr -3.32Cr -3.06Cr -2.87Cr -5.37Cr -365.57Cr -5.45Cr -36Cr -14Cr -177.94Cr -14Cr -14Cr -616.11Cr
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
15/26/15 59.50 kr -0.34% 30,200
12/26/12 59.70 kr +3.11% 50,507
11/26/11 57.90 kr +0.87% 31,364
10/26/10 57.40 kr 0.00% 1,02,319
09/26/09 57.40 kr -1.37% 60,795
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
59.70NOK
Average target price
85.00NOK
Spread / Average Target
+42.38%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!